Using novel chSiglec‐9 Jurkat/MA reporter cells, no Siglec‐9 signalling could be detected in any of the breast cancer cell lines, even though some cell lines displayed significant levels of Siglec‐9 ligands. This evidence concerns the gene SIGLEC9 and breast carcinoma.